- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Asthma; Chronic obstructive pulmonary disease (COPD)
- Meeting Date: July 2020
- Public Summary Document (PSD) March 2020 PBAC Meeting - (PDF 831KB)
- Public Summary Document (PSD) March 2020 PBAC Meeting - (Word 167KB)
Salbutamol – March 2020
Salbutamol: Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation), Ventolin®
Last updated
9 July 2025